Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
Objectives While important progress was made regarding the treatment of systemic sclerosis (SSc), there is still no evidence-based disease-modifying treatment available for SSc-related gastrointestinal (GI) manifestations. We aimed to identify an association between immunosuppressive therapy and the...
Saved in:
Main Authors: | Oliver Distler, Cosimo Bruni, Suzana Jordan, Carina Mihai, Muriel Elhai, Rucsandra Dobrota, Alexandru Garaiman, Mike Oliver Becker, Lea Stamm, Sherif Ismail, Norina Zampatti, Aurora Maria Tatu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/10/3/e004333.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation project
by: Maarten de Wit, et al.
Published: (2025-02-01) -
Immunosuppressants in modern approaches to treatment of inflammatory bowel diseases
by: O. B. Schukina, et al.
Published: (2013-05-01) -
An updated overview of Juvenile systemic sclerosis in a French cohort
by: Léa Jacquel, et al.
Published: (2025-02-01) -
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
by: David Munn, et al.
Published: (2021-10-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01)